Guorui Deng1, Justin L Grobe. 1. Department of Pharmacology, Center for Hypertension Research, Obesity Research & Education Initiative, Iowa Neuroscience Institute, Abboud Cardiovascular Research Center, and Fraternal Order of Eagles' Diabetes Research Center, Carver College of Medicine, University of Iowa, Iowa City, USA.
Abstract
PURPOSE OF REVIEW: Obesity represents the primary challenge to improving cardiovascular health, and suppression of resting metabolic rate (RMR) is implicated in the maintenance of obesity. Increasing evidence supports a major role for the renin-angiotensin system (RAS) within the brain in the control of RMR. RECENT FINDINGS: The angiotensin II (ANG) Agtr1a receptor colocalizes with the leptin receptor (Lepr) primarily within cells of the arcuate nucleus (ARC) of the hypothalamus that also express Agouti-related peptide (Agrp). This sub-population of Agtr1a receptors is required for stimulation of thermogenic sympathetic nervous activity and RMR, but not the suppression of food intake or increasing blood pressure, in response to various stimuli including high-fat diet, deoxycorticosterone acetate and salt, and leptin. Agtr1a is localized to a specific subset (SST3) of Agrp neurons within the ARC. SUMMARY: The RAS within the ARC is implicated specifically in RMR control, primarily through Agtr1a localized to the SST3 subset of Agrp neurons. Ongoing research is focused on understanding the unique anatomical projections, neurotransmitter utilization, and signal transduction pathways of Agtr1a within this subset of neurons. Understanding these projections and molecular mechanisms may identify therapeutic targets for RMR and thus obesity, independent of blood pressure and appetite.
PURPOSE OF REVIEW: Obesity represents the primary challenge to improving cardiovascular health, and suppression of resting metabolic rate (RMR) is implicated in the maintenance of obesity. Increasing evidence supports a major role for the renin-angiotensin system (RAS) within the brain in the control of RMR. RECENT FINDINGS: The angiotensin II (ANG) Agtr1a receptor colocalizes with the leptin receptor (Lepr) primarily within cells of the arcuate nucleus (ARC) of the hypothalamus that also express Agouti-related peptide (Agrp). This sub-population of Agtr1a receptors is required for stimulation of thermogenic sympathetic nervous activity and RMR, but not the suppression of food intake or increasing blood pressure, in response to various stimuli including high-fat diet, deoxycorticosterone acetate and salt, and leptin. Agtr1a is localized to a specific subset (SST3) of Agrp neurons within the ARC. SUMMARY: The RAS within the ARC is implicated specifically in RMR control, primarily through Agtr1a localized to the SST3 subset of Agrp neurons. Ongoing research is focused on understanding the unique anatomical projections, neurotransmitter utilization, and signal transduction pathways of Agtr1a within this subset of neurons. Understanding these projections and molecular mechanisms may identify therapeutic targets for RMR and thus obesity, independent of blood pressure and appetite.
Authors: T S Elton; C C Stephan; G R Taylor; M G Kimball; M M Martin; J N Durand; S Oparil Journal: Biochem Biophys Res Commun Date: 1992-04-30 Impact factor: 3.575
Authors: Pedro González-Muniesa; Miguel-Angel Mártinez-González; Frank B Hu; Jean-Pierre Després; Yuji Matsuzawa; Ruth J F Loos; Luis A Moreno; George A Bray; J Alfredo Martinez Journal: Nat Rev Dis Primers Date: 2017-06-15 Impact factor: 52.329
Authors: Nicole K Littlejohn; Henry L Keen; Benjamin J Weidemann; Kristin E Claflin; Kevin V Tobin; Kathleen R Markan; Sungmi Park; Meghan C Naber; Francoise A Gourronc; Nicole A Pearson; Xuebo Liu; Donald A Morgan; Aloysius J Klingelhutz; Matthew J Potthoff; Kamal Rahmouni; Curt D Sigmund; Justin L Grobe Journal: Cell Rep Date: 2016-07-28 Impact factor: 9.423
Authors: Nina Balthasar; Louise T Dalgaard; Charlotte E Lee; Jia Yu; Hisayuki Funahashi; Todd Williams; Manuel Ferreira; Vinsee Tang; Robert A McGovern; Christopher D Kenny; Lauryn M Christiansen; Elizabeth Edelstein; Brian Choi; Olivier Boss; Carl Aschkenasi; Chen-yu Zhang; Kathleen Mountjoy; Toshiro Kishi; Joel K Elmquist; Bradford B Lowell Journal: Cell Date: 2005-11-04 Impact factor: 41.582
Authors: I Sadaf Farooqi; Julia M Keogh; Giles S H Yeo; Emma J Lank; Tim Cheetham; Stephen O'Rahilly Journal: N Engl J Med Date: 2003-03-20 Impact factor: 91.245
Authors: Michael J Krashes; Bhavik P Shah; Joseph C Madara; David P Olson; David E Strochlic; Alastair S Garfield; Linh Vong; Hongjuan Pei; Mitsuko Watabe-Uchida; Naoshige Uchida; Stephen D Liberles; Bradford B Lowell Journal: Nature Date: 2014-02-02 Impact factor: 49.962
Authors: Christoffer Clemmensen; Brian Finan; Katrin Fischer; Robby Zachariah Tom; Beata Legutko; Laura Sehrer; Daniela Heine; Niklas Grassl; Carola W Meyer; Bart Henderson; Susanna M Hofmann; Matthias H Tschöp; Lex H T Van der Ploeg; Timo D Müller Journal: EMBO Mol Med Date: 2015-03 Impact factor: 12.137
Authors: Pablo B Pedrianes-Martin; Marcos Martin-Rincon; David Morales-Alamo; Ismael Perez-Suarez; Mario Perez-Valera; Victor Galvan-Alvarez; David Curtelin; Pedro de Pablos-Velasco; Jose A L Calbet Journal: J Clin Hypertens (Greenwich) Date: 2021-11-30 Impact factor: 3.738
Authors: Mario Zanaty; Fernando A C Seara; Pablo Nakagawa; Guorui Deng; Natalia M Mathieu; Kirthikaa Balapattabi; Sadashiva S Karnik; Justin L Grobe; Curt D Sigmund Journal: Hypertension Date: 2020-11-30 Impact factor: 9.897